Moderna sues Pfizer for patent infringement in the US and Germany over covid 19 vaccine
The company emphasises that it is not seeking injunctive relief and is only looking at sales the defendants have made since March of this year
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.